Established Northeast CAP-Accredited molecular genetics laboratory in the Novitas Medicare MAC is open to acquisition. This laboratory is a well-built laboratory with a W2 sales force and a solid base of in-network insurance contracts including Medicare, several Medicaids and a difficult-to-find BCBS Highmark contract. 2022 Revenue was approximately over 4 million with a focus on infectious disease along with Next Generation Sequencing testing. This is an excellent opportunity for any group seeking to move into a laboratory with solid credentialing in the Novitas Medicare area. The listing price of the laboratory has yet to be determined. Owners are open to staying on board for a period of time to ensure a smooth transition.